Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

4

A case report of treatment with pegylated interferon alpha for Lamivudine-resistant chronic hepatitis B virus infection

Won Haing Hur , Hyun Young Woo , Soung Won Jeong , Chan Ran You , Si Hyun Bae , Jong Young Choi , Seung Kew Yoon

Clin Mol Hepatol. 2008;14(4):513-518. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.513

View: 4723 Download: 30 Crossref: 1

3

Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients Living in Daejeon and Chungcheong Province in Korea: A comparative study

Jeong Il Kim, M.D, Seok Hyun Kim, M.D., Byung Seok Lee, M.D., Heon Young Lee, M.D., Tae Hee Lee, M.D. Young Woo Kang, M.D. Hyang Ie Lee, M.D. An Na Kim, M.D. Soon Woo Nam, M.D. Byeong Chool Park, M.D. Hee Bok Chae, M.D. Seok Bae Kim, M.D. Il Han Song, M.D. Ji Young Park, M.D. Hong Su Kim, M.D.

Clin Mol Hepatol. 2008;14(4):493-502. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.493

View: 4588 Download: 21 Crossref: 9

1

Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients

Youn Jae Lee

Clin Mol Hepatol. 2008;14(4):443-445. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.443

View: 3796 Download: 21

3

Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection

Myoung Joo Kang, M.D., Eun Uk Jung, M.D., Sang Won Park, M.D., Paul Choi, M.D., Ji Hyun Kim, M.D., Sung Jae Park, M.D., Eun Taek Park, M.D., Youn Jae Lee, M.D., Sang Hyuk Lee, M.D., Sang Yong Seol, M.D.

Clin Mol Hepatol. 2008;14(3):318-330. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.318

View: 5392 Download: 33 Crossref: 18

Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C

Heon Ju Lee , Jong Ryul Eun , Jae Won Choi , Kyung Ok Kim , Hee Jung Moon

Clin Mol Hepatol. 2008;14(1):46-57. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.46

View: 4616 Download: 20 Crossref: 15

Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C

Kyoung Tae Kim , Sang Young Han , Jong Han Kim , Hyun Ah Yoon , Yang Hyun Baek , Min Ji Kim , Sung Wook Lee , Jin Seok Jang , Jong Hun Lee , Myung Hwan Roh

Clin Mol Hepatol. 2008;14(1):36-45. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.36

View: 4688 Download: 30 Crossref: 21

4

A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin

Youn Ho Kim , Woo Sik Han , Sun Jae Lee , Sung Nam Oh , Do Won Choi , Kwan Soo Byun , Jong Eun Yeon

Clin Mol Hepatol. 2007;13(3):419-422. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.419

View: 4229 Download: 18

3

Short-term Therapy with Pegylated Interferon plus Ribavirin for the Chronic Hepatitis C Genotype 2 Patients

Eun Uk Jung , Ji Hun Park , Kyung Im Pae , Suk Woo Kang , Sung Jae Park , Sam Ryong Jee , Eun Tak Park , Youn Jae Lee , Sang Hyuk Lee , Sang Young Seol

Clin Mol Hepatol. 2007;13(3):341-348. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.341

View: 3964 Download: 21 Crossref: 2

1

Treatment of Chronic Hepatitis C: Shorter Treatment Duration For Genotype 2 or 3 Infection

Sook Hyang Jeong

Clin Mol Hepatol. 2007;13(3):301-303. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.301

View: 3407 Download: 19

4

Pulmonary Toxicity by Pegylated Interferon α-2a in a Patient with Chronic Hepatitis C

Byoung Kwan Son , Joo Hyun Sohn , Tae Yeob Kim , Yoon Kyung Park , Yong Chul Jeon , Dong Soo Han

Clin Mol Hepatol. 2007;13(1):103-107. Published online January 1, 1970

View: 2782 Download: 19

A Case of Bell`s Palsy Associated with Peginterferon Alfa-2a and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

Moo Yeol Lee, M.D., Hoon Cho, M.D., Yeong Muk Kim, M.D., and Joon Sang Lee, M.D.

Clin Mol Hepatol. 2006;12(3):444-448. Published online January 1, 2000

View: 2653 Download: 17

2

Immunology of Hepatitis C: Clinical Significance of T Cell Response

Eui Cheol Shin

Clin Mol Hepatol. 2006;12(2):140-153. Published online January 1, 1970

View: 2413 Download: 22

3

Peginterferon Alfa-2a plus Ribavirin for Initial Treatment of Chronic Hepatitis C in Korea

Hyuk Lee, M.D., Moon Seok Choi, M.D., Seung Woon Paik, M.D., Jeong Hwan Kim, M.D., Do Young Kim, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D. and Soon Mi Song, R.N.

Clin Mol Hepatol. 2006;12(1):31-40. Published online January 1, 1970

View: 3180 Download: 18

2

Treatment of Chronic Hepatitis B ; The Efficacy of Alpha-Interferon in Korean Patiens with Chronic Hepatitis B

Kwang Cheol Koh

Clin Mol Hepatol. 2005;11(1):31-33. Published online January 1, 2000

View: 2412 Download: 14

Treatment of Chronic Hepatitis B ; Dose and Treatment Duration of Regimen

Young Oh Kweon

Clin Mol Hepatol. 2005;11(1):13-16. Published online January 1, 2000

View: 2451 Download: 13

Treatment of Chronic Hepatitis B ; Indication of Drug Therapy in Patients with Chronic Hepatitis B

Mong Cho

Clin Mol Hepatol. 2005;11(1):1-8. Published online January 1, 2000

View: 2740 Download: 17

Peginterferon-alpha and Ribavirin Combination Therapy in Chronic Hepatitis C

Kwang Hyub Han , Young Hoon Yoon

Clin Mol Hepatol. 2004;10(2):81-87. Published online January 1, 1970

View: 2321 Download: 15

3

Recurrence and Management of Hepatitis C after Liver Transplantation

Ki Bong Oh, M.D., Sung Gyu Lee, M.D., Young Joo Lee, M.D., Kwang Min Park, M.D., Shin Hwang, M.D., Ki Hun Kim, M.D., Chul Soo Ahn, M.D., Deok Bog Moon, M.D., Chong Woo Chu, M.D., Hyun Seung Yang, M.D., Tae Yong Ha, M.D. and Sung Hoon Cho, M.D.

Clin Mol Hepatol. 2003;9(3):180-187. Published online January 1, 1970

View: 2613 Download: 13

Relationship Between Core Gene Mutations of Hepatitis B Virus and Response to Alpha Interferon Therapy in Chronic Hepatitis B

Byung Chul Yoo , Hyung Joon Kim , Jae Hyuk Do , Sill Moo Park

Clin Mol Hepatol. 2002;8(4):381-388. Published online January 1, 1970

View: 2381 Download: 23

2

Special Oromucosal Cytokine Therapy : Mechanism(s) of Action

Michael G. Tovey

Clin Mol Hepatol. 2002;8(2):125-131. Published online January 1, 1970

View: 4076 Download: 27

7

Comorbidities and Quality of Life in Patients with Interferon - Refractory Chronic Hepatitis C. Fontana RJ , Moyer CA , Sonnad S , et al. Am J Gastroenterol 2001 ; 96 ; 170 - 178

Byung Ik Kim

Clin Mol Hepatol. 2001;7(2):220-221. Published online January 1, 2000

View: 2381 Download: 13

3

Genotypes of Hepatitis C Virus and Short Term Efficacy of α-interferon Therapy in Patients with HCV Infection in Taegu

Jin Su Choi,Heon Ju Lee,Young Du Song,Soon Wook Kwun,Jong Yul Eun,Sun Taek Choi

Clin Mol Hepatol. 1999;5(1):22-32. Published online January 1, 2000

View: 2275 Download: 13

Long-term Follow-up of Patients Treated with Interferon Alfa for Chronic Hepatitis B

Jong Eun Yeon, M.D., Yeon Seok Seo, M.D., Yoon Hong Kim, M.D., Sang Hoon Park, M.D., Oh Sang Kwon, M.D., Kwan Soo Byun, M.D., and Chang Hong Lee, M.D.

Clin Mol Hepatol. 1999;5(1):12-21. Published online January 1, 2000

View: 2324 Download: 18

The Degree of TGF-p1 and a-SMA Expression in Liver Tissues with its Prognostic Value for the Therapeutic Efficacy of Interferon in Chronic Hepatitis B

Bai Young Kim, hee Jeong Ahn*, Seong Wook Oh, Oun Mi Jeong, Yu Jeong Choi, Jin Hwan Kook, Kyung Chul Kim, Sung Pyo Hong, Seong Gyu Hwang, Pil Won Park and Kyu Sung Rim

Clin Mol Hepatol. 1998;4(4):317-329. Published online January 1, 2000

View: 1992 Download: 13

Efficacy of Combination of Interferon α 2a , Ribavirin and UDCA in the Treatment of Chronic Hepatitis C

Dong Jin Suh , Neung Hwa Park , Young Hwa Chung , Young Sang Lee

Clin Mol Hepatol. 1998;4(2):109-119.

View: 2439 Download: 14

The Comparison of Adverse Effect and Short - term Effect of Different Dosage of Recombinant Interferon Alpha - 2b Treatment in Patients with Chronic Active Hepatitis Type B

Seok Hyun Kim , Jae Kyu Sung , Sang Ou Lee , Kyung Tae Lee , Seung Min Lee , Byung Seok Lee , Jin Hee Kim , Nam Jae Kim , Heon Young Lee

Clin Mol Hepatol. 1998;4(1):12-22.

View: 1970 Download: 11

Study of Long Term Follow - up of Interferon Therapy in Chronic Viral Hepatitis - in 222 cases during 127 weeks -

Jin Il Kim , Jong Soon Na , Choon Sang Bang , Soo Heon Park , Joon Yeol Han , Jeong Min Suh , Jae Kwang Kim , Young Seok Lee , Kyu Won Chung , Hee Sik Sun

Clin Mol Hepatol. 1997;3(3):241-251.

View: 2243 Download: 11

Factors Predictive of Response to Interferon Therapy in Chronic HCV Infection

Yun Soo Kim , So Young Kwan , Dong Jin Suh , Chang Hong Lee

Clin Mol Hepatol. 1996;2(2):176-185.

View: 19259 Download: 14

Efficacy of treatment with interferon alpha in hepatitis C

Heon Ju Lee , Jeong Ill Suh , Chan Won Park

Clin Mol Hepatol. 1996;2(2):166-175.

View: 2340 Download: 11

4

A Case of Hypothyroidism Induced by Alpha - Interferon Therapy for Chronic Hepatitis B

So Young Kwon , Jong Eun Yeon , Sei Hyun Baik , Jin Ho Kim , Young Tae Baik , Kwan Soo Byun , Chang Hong Lee

Clin Mol Hepatol. 1996;2(1):77-81.

View: 2166 Download: 12

1 | 2 | 3 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search